|
|
| Clinical Trial / Sentiment | Content |
|---|---|
| BESPOKE NEUTRAL
|
|
| EMERALD-1 NEUTRAL
|
|
| ECLIPSE POSITIVE
|
|
| ECLIPSE POSITIVE
|
|
| Company | Total | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
|
Merck Sharp & Dohme Corporation |
$15,440 |
$0 |
$0 |
$0 |
$0 |
$15,440 |
$0 |
$0 |
|
Merck Sharp & Dohme LLC |
$10,370 |
$0 |
$0 |
$0 |
$0 |
$0 |
$8,235 |
$2,135 |
|
Seagen Inc. |
$7,656 |
$0 |
$0 |
$0 |
$0 |
$0 |
$5,556 |
$2,100 |
|
Lilly USA, LLC |
$6,300 |
$0 |
$0 |
$0 |
$0 |
$6,300 |
$0 |
$0 |
|
EISAI INC. |
$4,684 |
$0 |
$0 |
$0 |
$0 |
$0 |
$4,684 |
$0 |
|
|
|
|
|
|
|
|
|
|
| Clinical Trial | Tweets | Peer Outreach | Peer Engagement |
| MRD | 2 | 0 | 9 |
| COLLISiON | 1 | 2 | 3 |